Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of Adjuvant Intravenous Irinotecan Following Resection With Or Without Radiofrequency Ablation (RFA), Of Hepatic Metastases From Colorectal Carcinoma

NCT00030563 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00030563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of Adjuvant Intravenous Irinotecan Following Resection With Or Without Radiofrequency Ablation (RFA), Of Hepatic Metastases From Colorectal Carcinoma
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2001
Completion date
October 31, 2005
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, metastatic cancer